Clinical trial
Flutamide In the Prevention of Prostate Cancer in Patients With Neoplasia of the…
NCT00006214 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00006214 |
|---|---|
| Title | Flutamide In the Prevention of Prostate Cancer in Patients With Neoplasia of the Prostate |
| Official title | Short-Term Chemoprevention Trial in Men With Prostatic Intraepithelial Neoplasia Using Flutamide as an Androgen Deprivation Agent |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug, Other |
| Interventions | flutamide, placebo |
| Enrollment | 63 |
| Start date | Aug 1, 2000 |
| Primary completion | Jul 1, 2006 |
| Completion | Jul 1, 2006 |
| First posted | Jun 22, 2004 |
| Last update posted | Jul 13, 2016 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: